Biofilm-inspired adhesive and antibacterial hydrogel with tough tissue integration performance for sealing hemostasis and wound healing

Biofilm-inspired adhesive and antibacterial hydrogel with tough tissue integration performance for sealing hemostasis and wound healing

Uncontrolled bleeding and infection can lead to a significant increase in mortality. Hydrogel sealant has attracted wide attention because of their ability to control bleeding. However, because water interface is a formidable barrier to a strong bonding surface, the challenge remains in finding a product that offers a strong network adhesion combined with anti-infective properties. Inspired by the mechanism of strong adhesive on the biofilm and mussels, we report a novel dual hydrogel adhesive bionic (DBAH) based on chitosan grafted with methacrylate (CS-MA), dopamine (DA), and N-hydroxymethyl acrylamide (NMA) through smooth a process radical polymerization.

CS-MA and DA simultaneously included in the adhesive polymer to mimic the key two-component adhesive: inter polysaccharide adhesin (PIA) on staphylococcal biofilms and 3,4-dihydroxy-L-phenylalanine (DOPA) of the protein shells foot, respectively. DBAH presented strong adhesion at 34 kPa even after three cycles of full immersion in water and can survive up to 168 mm Hg blood pressure, which is significantly higher than the 60-160 mm Hg measured in most clinical settings. Most importantly, these hydrogels presented remarkable hemostatic ability under wet and dynamic in vivo movement while displaying excellent antibacterial properties and biocompatibility. Therefore, DBAH a promising class of biomaterials for high efficiency hemostasis and wound healing.


The eluate denture adhesive is brought into contact with human gingival cells and compared to cells not treated (w / o any elution dental adhesives). cell toxicity was assessed by measuring cell viability (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide) (MTT) test), the morphology of the cells (immunofluorescence assay), induction of apoptosis / necrosis and the production of oxygen species reactive (ROS) (flow cytometry tests). In addition, the pH of each sample was determined. Data were analyzed using one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test.

 Biofilm-inspired adhesive and antibacterial hydrogel with tough tissue integration performance for sealing hemostasis and wound healing
Biofilm-inspired adhesive and antibacterial hydrogel with tough tissue integration performance for sealing hemostasis and wound healing

Chronic venous ulcers: a review of treatment with fibrin sealant and prognostic progress using proteomics strategy

Venous ulcers are a major cause of ulcers of lower-limb chronic. Difficulty healing encourage research and development of new products to achieve better therapeutic results. Fibrin sealant is one of the alternative routes. In addition to being validated scaffolding and drug delivery systems, it has excellent healing properties. This review covers the last 25 years of literature and shows that fibrin sealant used in a variety of clinical situations to promote the healing of various types of ulcers, particularly chronic. These are mostly veins in origin and usually do not respond to conventional treatment.

Commercially, only homologous fibrin sealant derived from human blood are available, which is very efficient but very expensive. The heterologous fibrin sealant is an experimental product non-commercial cost and easily manufactured because of the raw material. Phase I / II clinical trial has been completed and indicates that the product is safe and efficacious promisingly for the treatment of chronic venous ulcers. In addition, clinical proteomics strategy to assess the prognosis of the disease has been increasingly used.

pGB Caspase-8 siRNA Vector

9508-20 each
EUR 732

pGB Caspase-8 siRNA Vector

9508-60 each
EUR 1266

pGB Caspase-9 siRNA Vector

9509-20 each
EUR 732

pGB Caspase-9 siRNA Vector

9509-60 each
EUR 1266

siRNA Cloning Vector (pGB)

9500-20 each
EUR 352.8

pGB AIF siRNA Vector Mix

9511-20 each
EUR 732

pGB AIF siRNA Vector Mix

9511-60 each
EUR 1266

pGB BAD siRNA Vector Mix

9512-20 each
EUR 732

pGB BAD siRNA Vector Mix

9512-60 each
EUR 1266

pGB BAX siRNA Vector Mix

9513-20 each
EUR 732

pGB BAX siRNA Vector Mix

9513-60 each
EUR 1266

pGB BID siRNA Vector Mix

9515-20 each
EUR 732

pGB BID siRNA Vector Mix

9515-60 each
EUR 1266

pGB Hsp90 siRNA Vector Mix

9518-20 each
EUR 732

pGB Hsp90 siRNA Vector Mix

9518-60 each
EUR 1266

Control siRNA Vector (pGB-control)

9500C-20 each
EUR 405.6

pGB Bcl-2 siRNA Vector Mix

9514-20 each
EUR 732

pGB Bcl-2 siRNA Vector Mix

9514-60 each
EUR 1266

pGB CIAP-1 siRNA Vector Mix

9516-20 each
EUR 732

pGB CIAP-1 siRNA Vector Mix

9516-60 each
EUR 1266

pGB CIAP-2 siRNA Vector Mix

9517-20 each
EUR 732

pGB CIAP-2 siRNA Vector Mix

9517-60 each
EUR 1266

TranslationBlocker Human Caspase-3 siRNA, 2nmol

QX40-2nmol 2nmol
EUR 331.2

TranslationBlocker Human Caspase-3 siRNA, 10nmol

QX40-10nmol 10nmol
EUR 452.4

TranslationBlocker Human Caspase-1 siRNA, 1nmol

QX38-1nmol 1nmol
EUR 331.2

TranslationBlocker Human Caspase-1 siRNA, 5nmol

QX38-5nmol 5nmol
EUR 452.4

TranslationBlocker Human Caspase-2 siRNA, 2nmol

QX39-2nmol 2nmol
EUR 331.2

TranslationBlocker Human Caspase-6 siRNA, 2nmol

QX41-2nmol 2nmol
EUR 331.2

TranslationBlocker Human Caspase-7 siRNA, 2nmol

QX42-2nmol 2nmol
EUR 331.2

TranslationBlocker Human Caspase-8 siRNA, 2nmol

QX43-2nmol 2nmol
EUR 331.2

TranslationBlocker Human Caspase-2 siRNA, 10nmol

QX39-10nmol 10nmol
EUR 452.4

TranslationBlocker Human Caspase-6 siRNA, 10nmol

QX41-10nmol 10nmol
EUR 452.4

TranslationBlocker Human Caspase-7 siRNA, 10nmol

QX42-10nmol 10nmol
EUR 452.4

TranslationBlocker Human Caspase-8 siRNA, 10nmol

QX43-10nmol 10nmol
EUR 452.4

Rat Caspase-3(Caspase-3)ELISA Kit

NSL1646r 96 Tests
EUR 498

Goat Caspase-3(Caspase-3) ELISA Kit

NSL1101Gt 96T
EUR 528

Human Caspase-3(Caspase-3) ELISA Kit

NSL2230Hu 96 wells
EUR 468

Mouse Caspase-3(Caspase-3) ELISA Kit

NSL1622m 96 Test
EUR 528

Canine Caspase-3(Caspase-3) ELISA Kit

NSL0034Ca 129 wells
EUR 528

Bovine Caspase-3(Caspase-3) ELISA Kit

NSL2111Bo 96 T
EUR 528

Chicken Caspase-3(Caspase-3)ELISA Kit

NSL1199Ch 1294 T
EUR 528

Porcine Caspase-3(Caspase-3)ELISA Kit

NSL0992Po 96T
EUR 528

Caspase-3

MO15136 100 ug
EUR 559.2

Caspase-3

GT15044 100 ug
EUR 600

Caspase-3

E8ER1802-42 100ul
EUR 275
Description: Available in various conjugation types.

Caspase-3

E8ER30804 100ul
EUR 275
Description: Available in various conjugation types.

Caspase-3

E8ET1602-39 100ul
EUR 275
Description: Available in various conjugation types.

Guinea pig Caspase-3(Caspase-3) ELISA Kit

NSL1175Gp 96T
EUR 528

Caspase-3/CPP32/ Rat Caspase- 3/ CPP32 ELISA Kit

ELA-E0626r 96 Tests
EUR 1063.2

Caspase-3, active

RA15046 50 ug
EUR 459.6

Active Caspase-3

E8ET1602-47 100ul
EUR 275
Description: Available in various conjugation types.

Caspase-3 Peptide

3445P 0.05 mg
EUR 197.7
Description: (IN) Caspase-3 peptide

Caspase-3 Antibody

25442-100ul 100ul
EUR 468

Caspase-3 Antibody

3138-100 each
EUR 430.8

Caspase-3 Antibody

3138-30T each
EUR 175.2

Caspase-3 Antibody

3445-002mg 0.02 mg
EUR 206.18
Description: Caspase-3 Antibody: Caspases are a family of cysteine proteases that can be divided into the apoptotic and inflammatory caspase subfamilies. Unlike the apoptotic caspases, members of the inflammatory subfamily are generally not involved in cell death but are associated with the immune response to microbial pathogens. The apoptotic subfamily can be further divided into initiator caspases, which are activated in response to death signals, and executioner caspases, which are activated by the initiator caspases and are responsible for cleavage of cellular substrates that ultimately lead to cell death. Caspase-3 is synthesized as an inactive proenzyme that undergoes proteolytic cleavage by caspases 8, 9 and 10 to produce 2 subunits, termed p20 and p11. These subunits dimerize to form the active enzyme. Caspase-3 proteolytically cleaves and activates other proteins such as caspases 6, 7 and 9.

Caspase-3 Antibody

3445-01mg 0.1 mg
EUR 523.7
Description: Caspase-3 Antibody: Caspases are a family of cysteine proteases that can be divided into the apoptotic and inflammatory caspase subfamilies. Unlike the apoptotic caspases, members of the inflammatory subfamily are generally not involved in cell death but are associated with the immune response to microbial pathogens. The apoptotic subfamily can be further divided into initiator caspases, which are activated in response to death signals, and executioner caspases, which are activated by the initiator caspases and are responsible for cleavage of cellular substrates that ultimately lead to cell death. Caspase-3 is synthesized as an inactive proenzyme that undergoes proteolytic cleavage by caspases 8, 9 and 10 to produce 2 subunits, termed p20 and p11. These subunits dimerize to form the active enzyme. Caspase-3 proteolytically cleaves and activates other proteins such as caspases 6, 7 and 9.

Caspase-3 Antibody

48562-100ul 100ul
EUR 399.6

Caspase-3 Antibody

48562-50ul 50ul
EUR 286.8

Caspase-3 Antibody

48658-100ul 100ul
EUR 399.6

Caspase-3 Antibody

48658-50ul 50ul
EUR 286.8

Caspase-3 Antibody

F50514-0.08ML 0.08 ml
EUR 140.25
Description: CASP3 is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 6, 7 and 9, and the protein itself is processed by caspases 8, 9 and 10. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimer's disease.

Caspase-3 Antibody

F50514-0.4ML 0.4 ml
EUR 322.15
Description: CASP3 is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 6, 7 and 9, and the protein itself is processed by caspases 8, 9 and 10. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimer's disease.

Caspase-3 Antibody

F52416-0.08ML 0.08 ml
EUR 140.25
Description: Involved in the activation cascade of caspases responsible for apoptosis execution. At the onset of apoptosis it proteolytically cleaves poly(ADP-ribose) polymerase (PARP) at a '216-Asp-|-Gly-217' bond. Cleaves and activates sterol regulatory element binding proteins (SREBPs) between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain. Cleaves and activates caspase-6, -7 and -9. Involved in the cleavage of huntingtin. Triggers cell adhesion in sympathetic neurons through RET cleavage.

Caspase-3 Antibody

F52416-0.4ML 0.4 ml
EUR 330.65
Description: Involved in the activation cascade of caspases responsible for apoptosis execution. At the onset of apoptosis it proteolytically cleaves poly(ADP-ribose) polymerase (PARP) at a '216-Asp-|-Gly-217' bond. Cleaves and activates sterol regulatory element binding proteins (SREBPs) between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain. Cleaves and activates caspase-6, -7 and -9. Involved in the cleavage of huntingtin. Triggers cell adhesion in sympathetic neurons through RET cleavage.

Caspase-3 Antibody

F41376-0.08ML 0.08 ml
EUR 140.25
Description: This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 6, 7 and 9, and the protein itself is processed by caspases 8, 9 and 10. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimer's disease. Alternative splicing of this gene results in two transcript variants that encode the same protein. [provided by RefSeq].

Caspase-3 Antibody

F41376-0.4ML 0.4 ml
EUR 322.15
Description: This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 6, 7 and 9, and the protein itself is processed by caspases 8, 9 and 10. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimer's disease. Alternative splicing of this gene results in two transcript variants that encode the same protein. [provided by RefSeq].

Caspase-3 Antibody

F48960-0.08ML 0.08 ml
EUR 140.25
Description: This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 6, 7 and 9, and the protein itself is processed by caspases 8, 9 and 10. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimer's disease. Alternative splicing of this gene results in two transcript variants that encode the same protein.

Caspase-3 Antibody

F48960-0.4ML 0.4 ml
EUR 322.15
Description: This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 6, 7 and 9, and the protein itself is processed by caspases 8, 9 and 10. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimer's disease. Alternative splicing of this gene results in two transcript variants that encode the same protein.

Caspase-3 Antibody

R20270-0.1ML 100ul
EUR 347.65
Description: This recombinant Caspase-3 antibody reacts to human full length caspase-3 (35 kDa) and the large fragment of caspase-3 resulting from cleavage (17 kDa).

Caspase-3 Antibody

R30358 100 ug
EUR 356.15
Description: Caspase-3, also known as YAMA, CPP32 or APOPAIN, is a member of the cysteine-aspartic acid protease family known to interact with family members -8 and -9. It is encoded by the CASP3 gene. Tiso et al.(1996) used radiation hybrid mapping to localize the gene to human chromosome 4q33-q35.1. Fernandes-Alnemri et al.(1994) found that overexpression of CASP3 in insect cells induced apoptosis. Coexpression of the two CASP3 subunits in insect cells also resulted in apoptosis. Tewari et al.(1995) showed that purified human CASP1 cleaved the CASP3 proenzyme into a proteolytically active form and that activated Caspase-3 cleaved PARP into the 85-kD apoptotic form.

Caspase-3 Antibody

R30947 100 ug
EUR 356.15
Description: Cysteine-aspartic acid protease 3, also known as Apopain, CPP32, CPP32B, and YAMA, is a member of the cysteine-aspartic acid protease family. Western blot analysis of three cell lines revealed the prominent CASP3 band at 32 kD and 20 kD. Several human cancer cell lines showed coexpression of both variants at the mRNA and protein levels. Overexpression of the catalytically inactive Caspase-3 by human kidney cells offered some resistance to inducers of apoptosis, and CASP3 accumulation could be enhanced with addition of proteasome inhibitors. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Alternative splicing of this gene results in two transcript variants that encode the same protein. Orthologs have been identified in numerous mammals for which complete genome data are available. Unique orthologs are also present in birds, lizards, lissamphibians, and teleosts. Nicholson et al. developed a potent peptide aldehyde inhibitor and showed that it prevented apoptotic events in vitro, suggesting that the protein is important for the initiation of apoptotic cell death.

Caspase-3 Antibody

R31065 100 ug
EUR 356.15
Description: Caspase-3 is a caspase protein which interacts with Survivin, XIAP, CFLAR, Caspase 8, HCLS1, Deleted in Colorectal Cancer, TRAF3 and GroEL. This gene which is located at 4q35 encodes a protein that is a member of the cysteine-aspartic acid protease(caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes that undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 6, 7, and 9; and the protein itself is processed by caspases 8, 9, and 10. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimers disease. And the caspase-3 activation in heart failure sequentially cleaves SRF and generates a truncated SRF that appears to function as a dominant-negative transcription factor. Additionally, the caspase-3 influence on bone mineral density should be considered in any in vivo application of caspase-3 inhibitors to the treatment of human disease. In erythroid precursors undergoing terminal differentiation, Hsp70 prevents active CASP3 from cleaving GATA1 and inducing apoptosis.

Caspase-3 Antibody

R31602 100 ug
EUR 356.15
Description: Caspase-3 is an enzyme which interacts with Survivin, XIAP, CFLAR, CASP8, HCLS1, Deleted in Colorectal Cancer, TRAF3 and GroEL. This gene which is located on 4q35 encodes a protein that is a member of the cysteine-aspartic acid protease family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. They exist as inactive proenzymes that undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. CASP3 is the predominant cysteine-aspartic acid protease involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimers disease. And protein activation in heart failure sequentially cleaves SRF and generates a truncated SRF that appears to function as a dominant-negative transcription factor. Additionally, the proteins influence on bone mineral density should be considered in any in vivo application of Caspase-3 inhibitors to the treatment of human disease. In erythroid precursors undergoing terminal differentiation, Hsp70 prevents active CASP3 from cleaving GATA1 and inducing apoptosis.

Caspase-3 Antibody

RQ4904 100 ug
EUR 356.15
Description: Caspase 3 is a caspase protein which interacts with Survivin, XIAP, CFLAR, Caspase 8, HCLS1, Deleted in Colorectal Cancer, TRAF3 and GroEL. This gene which is located on 4q35 encodes a protein that is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes that undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimer's disease. And the caspase-3 activation in heart failure sequentially cleaves SRF and generates a truncated SRF that appears to function as a dominant-negative transcription factor. Additionally, the caspase-3 influence on bone mineral density should be considered in any in vivo application of caspase-3 inhibitors to the treatment of human disease. In erythroid precursors undergoing terminal differentiation, Hsp70 prevents active CASP3 from cleaving GATA1 and inducing apoptosis.

Caspase-3 Antibody

RQ4905 100 ug
EUR 356.15
Description: Caspase 3 is a caspase protein which interacts with Survivin, XIAP, CFLAR, Caspase 8, HCLS1, Deleted in Colorectal Cancer, TRAF3 and GroEL. This gene which is located on 4q35 encodes a protein that is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes that undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimer's disease. And the caspase-3 activation in heart failure sequentially cleaves SRF and generates a truncated SRF that appears to function as a dominant-negative transcription factor. Additionally, the caspase-3 influence on bone mineral density should be considered in any in vivo application of caspase-3 inhibitors to the treatment of human disease. In erythroid precursors undergoing terminal differentiation, Hsp70 prevents active CASP3 from cleaving GATA1 and inducing apoptosis.

Caspase-3 Antibody

E90214 100ul
EUR 255
Description: Available in various conjugation types.

pro Caspase 3

E8ET1603-26 100ul
EUR 275
Description: Available in various conjugation types.

Caspase 3 protein

30R-2319 25 units
EUR 278.4
Description: Purified recombinant Human Caspase 3 protein

Caspase 3 protein

30R-2327 25 units
EUR 337.2
Description: Purified recombinant Human Caspase 3 protein

Caspase 3 protein

30R-2329 25 units
EUR 337.2
Description: Purified recombinant Human Caspase 3 protein

Caspase 3 protein

30R-2414 5 ug
EUR 583.2
Description: Purified recombinant Human Caspase 3 protein

Caspase 3 protein

E20-80020 20ug
EUR 489.6

Caspase 3 protein

E20-80021 20ug
EUR 489.6

Human Caspase-3 (CASP3)

1-CSB-EP004548HU
  • EUR 456.00
  • EUR 256.80
  • EUR 1570.80
  • EUR 672.00
  • EUR 1047.60
  • EUR 314.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Caspase-3(CASP3),partial expressed in E.coli

Caspase 3 antibody

20R-2495 50 ug
EUR 337.2
Description: Rabbit polyclonal Caspase 3 antibody

Caspase 3 antibody

20R-CR013 50 ug
EUR 620.4
Description: Rabbit polyclonal Caspase 3 antibody

Caspase 3 Antibody

21420-100ul 100ul
EUR 302.4

Caspase 3 Antibody

21420-50ul 50ul
EUR 224.4

Caspase 3 antibody

20R-1424 100 ug
EUR 937.2
Description: Rabbit polyclonal Caspase 3 antibody

Caspase 3 antibody

20R-1469 100 ug
EUR 781.2
Description: Rabbit polyclonal Caspase 3 antibody

Caspase 3 antibody

70R-31075 100 ug
EUR 392.4
Description: Rabbit polyclonal Caspase 3 antibody

Caspase 3 antibody

70R-31076 100 ug
EUR 392.4
Description: Rabbit polyclonal Caspase 3 antibody

Caspase 3 antibody

70R-31077 100 ug
EUR 392.4
Description: Rabbit polyclonal Caspase 3 antibody

Caspase 3 antibody

70R-11558 100 ug
EUR 774
Description: Rabbit polyclonal Caspase 3 antibody

Caspase 3 antibody

70R-11638 100 ug
EUR 564
Description: Rabbit polyclonal Caspase 3 antibody

Caspase 3 antibody

70R-13844 100 ug
EUR 386.4
Description: Affinity purified Rabbit polyclonal Caspase 3 antibody

Caspase 3 antibody

70R-33463 100 ug
EUR 392.4
Description: Rabbit polyclonal Caspase 3 antibody

Caspase 3 antibody

70R-49456 100 ul
EUR 292.8
Description: Purified Polyclonal Caspase 3 antibody

Caspase 3 antibody

70R-49457 100 ul
EUR 292.8
Description: Purified Polyclonal Caspase 3 antibody

Caspase 3 antibody

70R-49458 100 ul
EUR 292.8
Description: Purified Polyclonal Caspase 3 antibody

Caspase 3 Antibody

ABF6311 100 ug
EUR 525.6

Caspase 3 antibody

PAab10013 100 ug
EUR 463.2

Caspase 3 Antibody

E021420 100μg/100μl
EUR 255
Description: Available in various conjugation types.

Caspase 3 Antibody

E18-6311-1 50μg/50μl
EUR 145
Description: Available in various conjugation types.

Caspase 3 Antibody

E18-6311-2 100μg/100μl
EUR 225
Description: Available in various conjugation types.

Caspase 3 Antibody

E300261 200ul
EUR 275
Description: Available in various conjugation types.

Caspase 3 antibody

CAF50445-100ug 100ug
EUR 338

Caspase 3 Antibody

R35575-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: CASP3, SCA-1, YAMA, Apopain

Caspase 3 Antibody

E38PA6370 100ul
EUR 225
Description: Available in various conjugation types.

Caspase 3 Antibody

E38PA1137 100ul
EUR 225
Description: Available in various conjugation types.

Caspase 3 Antibody

E38PA1138 100ul
EUR 225
Description: Available in various conjugation types.

Caspase 3 Antibody

E38PA1139 100ul
EUR 225
Description: Available in various conjugation types.

Caspase 3 Antibody

DF6879 100ul
EUR 280
Description: Human,Mouse,Rat

Caspase 3 Antibody

AF6311-100ul 100ul
EUR 280

Caspase 3 Antibody

AF6311-200ul 200ul
EUR 350

Caspase 3 Antibody

DF6020-100ul 100ul
EUR 280

Caspase 3 Antibody

DF6020-200ul 200ul
EUR 350

Caspase 3 Antibody

DF6879-100ul 100ul
EUR 280

Caspase 3 Antibody

DF6879-200ul 200ul
EUR 350

Caspase 3 Antibody

AF6311 100ul
EUR 280
Description: Human,Mouse,Rat,Bovine

Caspase 3 Antibody

DF6020 100ul
EUR 280
Description: Human,Mouse,Rat

Caspase-3-IN-1

T63479-10mg 10mg Ask for price
Description: Caspase-3-IN-1

Caspase-3-IN-1

T63479-1g 1g Ask for price
Description: Caspase-3-IN-1

Caspase-3-IN-1

T63479-1mg 1mg Ask for price
Description: Caspase-3-IN-1

Caspase-3-IN-1

T63479-50mg 50mg Ask for price
Description: Caspase-3-IN-1

Caspase-3-IN-1

T63479-5mg 5mg Ask for price
Description: Caspase-3-IN-1

Caspase-3 Mouse mAb

A17900-100ul 100 ul
EUR 460.8

Caspase-3 Mouse mAb

A17900-200ul 200 ul
EUR 664.8

Caspase-3 Mouse mAb

A17900-20ul 20 ul
EUR 265.2

Caspase-3 Mouse mAb

A17900-50ul 50 ul
EUR 318

Caspase-3 Mouse mAb

A17900 20μL
EUR 128.7
Description: A synthetic peptide corresponding to a sequence within amino acids 479-578 of human NADPH oxidase 4 (NOX4) (NP_058627.2).

Caspase-3 Mouse mAb

E2221248 100ul
EUR 225
Description: Available in various conjugation types.

Caspase-3 Mouse mAb

E2221254 100ul
EUR 225
Description: Available in various conjugation types.

Caspase-3 Rabbit pAb

A11040-100ul 100 ul
EUR 369.6

Caspase-3 Rabbit pAb

A11040-200ul 200 ul
EUR 550.8

Caspase-3 Rabbit pAb

A11040-20ul 20 ul
EUR 219.6

Caspase-3 Rabbit pAb

A11040-50ul 50 ul
EUR 267.6

Caspase-3 Rabbit pAb

A11319-100ul 100 ul
EUR 369.6

Caspase-3 Rabbit pAb

A11319-200ul 200 ul
EUR 550.8

Caspase-3 Rabbit pAb

A11319-20ul 20 ul
EUR 219.6

Caspase-3 Rabbit pAb

A11319-50ul 50 ul
EUR 267.6

Caspase-3 Rabbit pAb

A11953-100ul 100 ul
EUR 369.6

Caspase-3 Rabbit pAb

A11953-200ul 200 ul
EUR 550.8

Caspase-3 Rabbit pAb

A11953-20ul 20 ul
EUR 219.6

Caspase-3 Rabbit pAb

A11953-50ul 50 ul
EUR 267.6

Caspase-3 Rabbit pAb

A16793-100ul 100 ul
EUR 369.6

Caspase-3 Rabbit pAb

A16793-200ul 200 ul
EUR 550.8

Caspase-3 Rabbit pAb

A16793-20ul 20 ul
EUR 219.6

Caspase-3 Rabbit pAb

A16793-50ul 50 ul
EUR 267.6

Caspase-3 Rabbit pAb

A16794-100ul 100 ul
EUR 369.6

Caspase-3 Rabbit pAb

A16794-200ul 200 ul
EUR 550.8

Caspase-3 Rabbit pAb

A16794-20ul 20 ul
EUR 219.6

Caspase-3 Rabbit pAb

A16794-50ul 50 ul
EUR 267.6

Caspase-3 Rabbit pAb

A0214-100ul 100 ul
EUR 369.6

Caspase-3 Rabbit pAb

A0214-200ul 200 ul
EUR 550.8

Caspase-3 Rabbit pAb

A0214-20ul 20 ul
EUR 219.6

Caspase-3 Rabbit pAb

A0214-50ul 50 ul
EUR 267.6

Caspase-3 Rabbit pAb

E2346997 100ul
EUR 225
Description: Available in various conjugation types.

Caspase-3 Rabbit pAb

E2380189 100ul
EUR 225
Description: Available in various conjugation types.

Caspase-3 Rabbit pAb

E2382842 100ul
EUR 225
Description: Available in various conjugation types.

Caspase-3 Rabbit pAb

E2251967 100ul
EUR 225
Description: Available in various conjugation types.

By analyzing a sample of fluid from the wound through proteomics strategy, it is possible to predict before treatment ulcers will develop positively and which will be difficult to cure. This prognosis is only possible to evaluate the expression of proteins isolated in exudate and analysis using free label strategy for the shotgun. multicentre clinical trials will be required to evaluate the efficacy of fibrin sealant to treat chronic ulcers, as well as to validate the proteomics strategies for assessing prognosis.

Leave A Comment